| Literature DB >> 27658856 |
Philipp Born1, Thomas Ilchmann2,3, Werner Zimmerli2, Lukas Zwicky1, Peter Graber2, Peter E Ochsner1,2, Martin Clauss1,2.
Abstract
Background and purpose - The use of uncemented revision stems is an established option in 2-stage procedures in patients with periprosthetic joint infection (PJI) after total hip arthroplasty (THA). However, in 1-stage procedures, they are still rarely used. There are still no detailed data on radiological outcome after uncemented 1-stage revisions. We assessed (1) the clinical outcome, including reoperation due to persistent infection and any other reoperation, and (2) the radiological outcome after 1- and 2-stage revision, using an uncemented stem. Patients and methods - Between January 1993 and December 2012, an uncemented revision stem was used in 81 THAs revised for PJI. Patients were treated with 1- or 2-stage procedures according to a well-defined algorithm (1-stage: n = 28; 2-stage: n = 53). All hips had a clinical and radiological follow-up. Outcome parameters were eradication of infection, re-revision of the stem, and radiological changes. Survival was calculated using Kaplan-Meier analysis. Radiographs were analyzed for bone restoration and signs of loosening. The mean clinical follow-up time was 7 (2-15) years. Results - The 7-year infection-free survival was 96% (95% CI: 92-100), 100% for 1-stage revision and 94% for 2-stage revision (95% CI: 87-100) (p = 0.2). The 7-year survival for aseptic loosening of the stem was 97% (95% CI: 93-100), 97% for 1-stage revision (95% CI: 90-100) and 97% for 2-stage revision (95% CI: 92-100) (p = 0.3). No further infection or aseptic loosening occurred later than 7 years postoperatively. The radiographic results were similar for 1- and 2-stage procedures. Interpretation - Surgical management of PJI with stratification to 1- or 2-stage exchange according to a well-defined algorithm combined with antibiotic treatment allows the safe use of uncemented revision stems. Eradication of infection can be achieved in most cases, and medium- and long-term results appear to be comparable to those for revisions for aseptic loosening.Entities:
Mesh:
Substances:
Year: 2016 PMID: 27658856 PMCID: PMC5119449 DOI: 10.1080/17453674.2016.1237423
Source DB: PubMed Journal: Acta Orthop ISSN: 1745-3674 Impact factor: 3.717
Figure 1.Surgical treatment algorithm for prosthetic joint infections. Modified according to Trampuz and Zimmerli (2005).
Figure 2.57-year-old male patient (2-stage exchange, ETO, Wagner SL, ARR). Girdlestone hip (a) due to difficult-to-treat bacteria (small-colony variant of S. aureus), postoperatively (b), and after 3 months (c). Complete remodeling of the proximal femur at 5 years (d).
Etiology of the 81 episodes of PJI. The total number of microorganisms was higher than the number of episodes, because 14 episodes were polymicrobial
| Bacteria | Total no. | 1-stage | 2-stage |
|---|---|---|---|
| Coagulase-negative staphylococci | 27 | 11 | 16 |
| 26 | 7 | 19 | |
| 14 | 6 | 8 | |
| 9 | 3 | 6 | |
| 5 | 1 | 4 | |
| 2 | 0 | 2 | |
| 2 | 0 | 2 | |
| 2 | 0 | 2 | |
| 1 | 0 | 1 | |
| 1 | 0 | 1 | |
| No growth | 4 | 1 | 3 |
Difficult-to-treat microorganisms as defined by Zimmerli et al. (2004) and Trampuz and Zimmerli (2005).
1 Escherichia coli strain and 2 Staphylococcus aureus strains were small-colony variants (Sendi et al. 2006) that were also defined as difficult-to-treat (see above).
Figure 3.Kaplan-Meier survival with revision for infection as endpoint after 7 years was 100% for 1-stage exchange and 94% (95% CI: 87–100) for 2-stage exchange. There was no statistically significant difference between the groups (p = 0.2).
Figure 4.Kaplan-Meier survival with revision for aseptic stem loosening as endpoint after 7 years was 96% (95% CI: 90–100) for 1-stage exchange and 97% (95% CI: 92–100) for 2-stage exchange. There was no statistically significant difference between the groups (p = 0.8).
Figure 5.Kaplan-Meier survival with revision for any reason as endpoint after 7 years was 96% (95% CI: 90–100) for 1-stage exchange and 87% (95% CI: 77–96) for 2-stage exchange. There was no statistically significant difference between the groups (p = 0.3).
Distribution of acetabular and femoral defects
| Total no. | 1-stage | 2-stage | |
|---|---|---|---|
| Acetabular defects, classification according to Paproski et al. ( | |||
| 0 | 26 | 17 | 9 |
| 1 | 8 | 3 | 5 |
| 2A | 17 | 4 | 13 |
| 2B | 4 | 1 | 3 |
| 2C | 20 | 4 | 16 |
| 3A | 5 | 0 | 5 |
| 3B | 1 | 0 | 1 |
| Femoral defects, classification according to Pak et al. ( | |||
| 0 | 3 | 2 | 1 |
| I | 7 | 4 | 3 |
| II | 39 | 20 | 19 |
| IIIA | 30 | 3 | 27 |
| IIIB | 2 | 0 | 2 |
| IV | 0 | 0 | 0 |
Summary of the literature concerning 1- and 2-stage cementless revisions in PJI
| N | Follow-up, years | Implant retention (%) | Bone grafts | |
|---|---|---|---|---|
| 1-stage | ||||
| Bori et al. 2014 | 24 | 2.7 | 96 | 2 cases |
| Ilchmann et al. 2015 | 39 | 6.6 | 100 | |
| Winkler et al. | 37 | 4.4 | 92 | a |
| Yoo et al. 2009 | 12 | 7.2 | 83 | 8 cases |
| Zeller et al. | 157 | 3.5 | 95 | |
| 2-stage | ||||
| Dieckmann et al. | 43 | 3.9 | 93 | ND |
| Fink et al. | 36 | 2.9 | 100 | ND |
| Kim et al. | 294 | 10.4 | 98 | Yes |
| Koo et al. | 22 | 3.4 | 95 | ND |
| Masri et al. | 29 | > 2 | 90 | ND |
| Neumann et al. | 44 | 5.6 | 98 | ND |
| Romano et al. | 20 | 4.7 | 95 | ND |
Impregnated impaction grafting
ND: No data